Гепарин-индуцированная тромбоцитопения на фоне приема низкомолекулярного гепарина у пациентки после протезирования аортального клапана механическим протезом

1. Петрова О.В., Шашин С.А., Тарасов Д.Г., Мартьянова Ю.Б., Кадыкова А.В., Уртаева З.А., Жукова Е.Р. Гепарининдуцированная тромбоцитопения у больных, оперированных по поводу хронической ревматической болезни сердца. Кардиология и сердечно-сосудистая хирургия. 2015;8(3):13–17. (Petrova OV, Shashin SA, Tarasov DG, Mart’yanova YuB, Kadykova AV, Urtaeva ZA, Zhukova ER. Heparin-induced thrombocytopenia in patients operated for chronic rheumatic heart disease. Kardiologiya i serdechno-sosudistaya khirurgiya = Cardiology and Cardiovascular Surgery. 2015;8(3):13–17 (In Russ.)).

EDN: ULFCND. https://doi.org/10.17116/kardio20158313-17

2. Watson H, Davidson S, Keeling D; Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: Second edition. Br J Haematol. 2012;159(5):528–40.

PMID: 23043677. https://doi.org/10.1111/bjh.12059

3. Seigerman M, Cavallaro P, Itagaki S, Chung I, Chikwe J. Incidence and outcomes of heparin-induced thrombocytopenia in patients undergoing cardiac surgery in North America: An analysis of the nationwide inpatient sample. J Cardiothorac Vasc Anesth. 2014;28(1):98–102.

PMID: 24295719. https://doi.org/10.1053/j.jvca.2013.07.021

4. Сугралиев А.Б. Гепарининдуцированная тромбоцитопения. Кардиология. 2024;64(5):18–25. (Sugraliev AB. Heparin-induced thrombocytopenia. Kardiologiya = Cardiology. 2024;64(5):18–25 (In Russ.)).

EDN: OTRWCK. https://doi.org/10.18087/cardio.2024.5.n2186

5. Васильев С.А., Горгидзе Л.А., Моисеева Т.Н., Аль-Ради Л.С., Зозуля Н.И., Соколова М.А., Мазуров А.В. Гепарининдуцированная тромбоцитопения (обзор). Атеротромбоз. 2019;(1):99–114. (Vasiliev SA, Gorgidze LA, Moiseeva TN, Al’-Radi LS, Zozulya NI, Sokolova MA, Mazurov AV. Heparin-induced thrombocytopenia (review). Atherothrombosis. 2019;(1):99–114 (In Russ.)).

EDN: ZTIQWL. https://doi.org/10.21518/2307-1109-2019-1-99-114

6. Tugulan C, Chang DD, Bates MJ. Heparin-induced thrombocytopenia after mitral valve replacement. Ochsner J. 2021;21(2):200–4.

https://doi.org/10.31486/toj.20.0007

7. Arepally GM, Padmanabhan A. Heparin-induced thrombocytopenia: A focus on thrombosis. Arterioscler Thromb Vasc Biol. 2021;41(1):141–52.

PMID: 33267665. PMCID: PMC7769912. https://doi.org/10.1161/atvbaha.120.315445

8. Naji FS, Shafie M, Issaiy M, Jalalabadi NZ, Parsa S. Delayed-onset heparin-induced thrombocytopenia complicated with saddle embolus. Clin Case Rep. 2022;10(7):e6085.

PMID: 35865782. PMCID: PMC9295682. https://doi.org/10.1002/ccr3.6085

9. Liu L, Zheng H, Chen S, Wang S, Yang M. Heparin-induced thrombocytopenia associated with low-molecular-weight heparin: Clinical feature analysis of cases and pharmacovigilance assessment of the FAERS database. Front Pharmacol. 2023;14:1247253.

PMID: 37808193. PMCID: PMC10552922. https://doi.org/10.3389/fphar.2023.1247253

10. Solanki J, Shenoy S, Downs E, , Palkimas S, Goldman S, Sharma AM. Heparin-induced thrombocytopenia and cardiac surgery. Semin Thorac Cardiovasc Surg. 2019;31(3): 335–44.

PMID: 30448485. https://doi.org/10.1053/j.semtcvs.2018.10.011

11. Pishko AM, Cuker A. Heparin-induced thrombocytopenia and cardiovascular surgery. Hematology Am Soc Hematol Educ Program. 2021;2021(1):536–44.

PMID: 34889428. PMCID: PMC8791147. https://doi.org/10.1182/hematology.2021000289

12. Ivascu NS, Fitzgerald M, Ghadimi K, Patel P, Evans AS, Goeddel LA et al. Heparin-induced thrombocytopenia: A review for cardiac anesthesiologists and intensivists. J Cardiothorac Vasc Anesth. 2019;33(2):511–20.

PMID: 30502310. https://doi.org/10.1053/j.jvca.2018.10.035

13. Larsen EL, Nilius H, Studt J-D, Tsakiris DA, Greinacher A, Mendez A et al. Accuracy of diagnosing heparin-induced thrombocytopenia. JAMA Netw Open. 2024;7(3):e243786.

PMID: 38530310. PMCID: PMC10966416. https://doi.org/10.1001/jamanetworkopen.2024.3786

14. Linkins L-A, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, Crowther M. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic therapy and prevention of thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e495S–e530S.

PMID: 22315270. PMCID: PMC3278058. https://doi.org/10.1378/chest.11-2303

15. Warkentin TE. Challenges in detecting clinically relevant heparin-induced thrombocytopenia antibodies. Hamostaseologie. 2020;40(4):472–84.

PMID: 33091948. PMCID: PMC7581458. https://doi.org/10.1055/a-1223-3329

16. Marcucci R, Berteotti M, Gori AM, , Giusti B, Rogolino AA, Sticchi E et al. Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfus. 2021;19(1):14–23.

PMID: 33370230. PMCID: PMC7850929. https://doi.org/10.2450/2020.0248-20

17. Zhou P, Yin J-X, Tao H-L, Zhang H-W. Pathogenesis and management of heparin-induced thrombocytopenia and thrombosis. Clin Chim Acta. 2020;504:73–80.

PMID: 32032610. https://doi.org/10.1016/j.cca.2020.02.002

18. Keles E, Bilen C, Aygun H, Gencpinar T, Catalyurek H. Non-heparin-induced thrombocytopenia in patients after open-heart surgery. Perfusion. 2023;38(4):781–90.

PMID: 35377248. https://doi.org/10.1177/02676591221082496

19. Wirth SM, Macaulay TE, Armitstead JA, Steinke DT, Blechner MD, Lewis DA. Evaluation of a clinical scoring scale to direct early appropriate therapy in heparin-induced thrombocytopenia. J Oncol Pharm Pract. 2010;16(3):161–66.

PMID: 19692430. https://doi.org/10.1177/1078155209342133

20. Greinacher A. Too many hits in HIT? Am J Hematol. 2007; 82(12): 1035–36.

PMID: 17729242. https://doi.org/10.1002/ajh.21047

21. Hvas A-M, Favaloro EJ, Hellfritzsch M. Heparin-induced thrombocytopenia: Pathophysiology, diagnosis and treatment. Expert Rev Hematol. 2021; 14(4): 335–46.

PMID: 33736552. https://doi.org/10.1080/17474086.2021.1905512

22. Hogan M, Berger JS. Heparin-induced thrombocytopenia (HIT): Review of incidence, diagnosis, and management. Vasc Med. 2020;25(2):160–73.

PMID: 32195628. https://doi.org/10.1177/1358863X19898253

23. Dhawan N. Beware of warfarin-induced skin necrosis in the setting of heparin-induced thrombocytopenia. Cureus. 2020;12(6):e8857.

PMID: 32754398. PMCID: PMC7386079. https://doi.org/10.7759/cureus.8857

24. Переверзева К.Г., Якушин С.С., Коршикова А.А. Возможности применения антикоагулянтной терапии в кардиологической практике при тромбоцитопении. Российский кардиологический журнал. 2023;28(8):98–105. (Pereverzeva KG, Yakushin SS, Korshikova AA. Potential of anticoagulant therapy in cardiology practice for thrombocytopenia. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2023;28(8):98–105 (In Russ.)).

EDN: PMFBPQ. https://doi.org/10.15829/1560-4071-20235408

25. Марченко И.А., Шиян А.В., Андреева А.С. Современные методы лабораторной диагностики гепарининдуцированной тромбоцитопении. Медицинский совет. 2017;(12):189–195. (Marchenko IA, Shiyan AV, Andreeva AS. Modern methods of laboratory diagnosis of heparin-induced thrombocytopenia. Meditsinskiy sovet = Medical Council. 2017;(12):189–195 (In Russ.)). EDN: ZQTJYL.